Silence Therapeutics (SLN) Current Leases (2019 - 2026)

Silence Therapeutics has disclosed Current Leases across 8 years of filings, most recently posting $93000.0 for Q1 2026.

• Current Leases for Q1 2026 came in at $93000.0, up 55.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $93000.0 (up 55.0% YoY), and the FY2025 annual result was $89000.0, down 23.93% from the prior year.
• Current Leases came in at $93000.0 for Q1 2026 at Silence Therapeutics, up from $89000.0 in the prior quarter.
• In the past five years, Current Leases ranged from a high of $523126.0 in Q4 2022 to a low of $60000.0 in Q1 2025.
• The 5-year median for Current Leases is $93000.0 (2026), against an average of $169898.9.
• Across the five-year window, Current Leases jumped 183.26% in 2022 and plunged 57.53% in 2023, its largest moves.
• Silence Therapeutics' Current Leases stood at $523126.0 in 2022, then slumped by 57.53% to $222166.2 in 2023, then sank by 47.34% to $117000.0 in 2024, then decreased by 23.93% to $89000.0 in 2025, then gained by 4.49% to $93000.0 in 2026.
• The last three Current Leases figures came in at $93000.0 (Q1 2026), $89000.0 (Q4 2025), and $85000.0 (Q3 2025), per Business Quant data.